Home › Premarket Biotech Digest: Valeant's M&A Prospects, Stocks Tumble, Novartis Promacta Extension
 

Keywords :   


Premarket Biotech Digest: Valeant's M&A Prospects, Stocks Tumble, Novartis Promacta Extension

2015-08-25 23:15:17| Biotech - Topix.net

The iShares NASDAQ Biotechnology Index ETF fell another 4% on Monday and is now down more than 11% in the last three trading sessions amid a selloff in the broader market. Not surprisingly, the question every biotech focused investor is asking right now is whether this is an opportunity to buy.

Tags: extension stocks prospects digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Hurricane Beryl Update Statement
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Forecast Discussion Number 8
30.06Hurricane Beryl Public Advisory Number 8
30.06Hurricane Beryl Wind Speed Probabilities Number 8
30.06Hurricane Beryl Forecast Advisory Number 8
30.06Weekly Recap: Rockline Wins WOW Innovation Award, Hospeco Purchases Nuance Solutions & More
More »